← Back to Search

Electronic Decision Support Tool

Electronic decision support for deprescribing (MedSafer tool) for Deprescribing (E-CARE Trial)

N/A
Waitlist Available
Led By Emily McDonald, MDCM
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial tests an electronic tool called MedSafer, which helps doctors and nurses in aged care facilities safely reduce or stop unnecessary medications for older adults. The tool analyzes patient information and provides real-time reports on which medications can be safely adjusted. This helps healthcare providers manage complex medication regimens more effectively.

Eligible Conditions
  • Deprescribing
  • Overmedication
  • Adverse Drug Reactions

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of patients with one or more PIM (potentially inappropriate medication) reduced or stopped
Secondary study objectives
Sustainability; quality of life; sleep quality; falls; transfer to acute hospital; hip fractures; and delirium
Other study objectives
Cost savings

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention: MedSaferExperimental Treatment1 Intervention
In the intervention phase, the MedSafer feature will become accessible in MED e-care for the physicians, pharmacists and nurses. This feature will provide health care professionals with individualized and prioritized deprescribing opportunities: a) identifying the medication, b) explaining why that medication is potentially inappropriate and c) providing instructions on how to safely stop/taper the medication. The user will review these opportunities and appropriate candidate medications for deprescribing can then be tapered or stopped directly in the EMR. During the intervention phase, all patients will receive the educational (EMPOWER) brochures as applicable to the medications they are taking (PPI, sedative-hypnotic, antihistamine, antipsychotic, sulfonylurea, NSAID, opioid/narcotic).
Group II: Control: Baseline (no MedSafer)Active Control1 Intervention
During the control phase, the MedSafer application programming interface will not be accessible to the caretakers at the aged care facilities (ACF). This serves to obtain baseline deprescribing levels for each ACF.

Find a Location

Who is running the clinical trial?

Centre for Aging and Brain Health InnovationOTHER
15 Previous Clinical Trials
5,200 Total Patients Enrolled
OMNI Health CareUNKNOWN
MED e-care Healthcare SolutionsUNKNOWN
~0 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top